Bioreclamation LLC has purchased Celsis In Vitro Technologies.

Baltimore-based Celsis provides in vitro products to study metabolism, drug-to-drug interactions and toxicity for medicine development. The company was sold by Chicago-based Celsis International, a company that provides tools for the pharmaceutical and consumer products industries.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.